INIFY Prostate® shown to accurately outline suspicious prostate cancer in study with two prominent medical centers
STOCKHOLM – October 18, 2021 – ContextVision, a medical technology software company specializing in image processing, image analysis and decision support tools for digital pathology, today announced that results from a US clinical evaluation were presented at the Pathology Visions Congress in Las Vegas, USA. The evaluation was performed together with two independent pathologists, Anil Parwani, M.D., Ph.D., M.B.A. at Ohio State University Comprehensive Cancer Center (Columbus, Ohio), and Ming Zhou, M.D., Ph.D., Chair and Pathologist-in-Chief at Tufts Medical Center (Boston, Massachusetts).